Effect of Continuous Ingestion of Bifidobacteria and Inulin on Reducing Body Fat: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Comparison Study DOI Open Access

Yuhei Baba,

Yasuo Saito,

Mei Kadowaki

и другие.

Nutrients, Год журнала: 2023, Номер 15(24), С. 5025 - 5025

Опубликована: Дек. 7, 2023

Bifidobacterium animalis subsp. lactis GCL2505 has been shown to have several positive health effects, including improved defecation frequency and reduced visceral fat. It is known that combined intake of inulin increases the total number bifidobacteria compared with ingestion alone. This randomized, double-blind, placebo-controlled, parallel-group study was conducted confirm consumption reduces abdominal fat (n = 120). Participants consumed a test beverage containing 1 × 1010 colony-forming units per 100 g 2.0 for 12 weeks. A change in area (VFA) set as primary endpoint. There were significant reductions VFA area. The intervention significantly increased affected levels lipid markers. Regression analysis measured parameters showed correlated body mass index (BMI), while endogenous only BMI, suggesting both contributed decrease VFA. These results suggest improves intestinal environment association SCFA-mediated pathway.

Язык: Английский

Fecal Microbiota Transplantation: Insights into Colon Carcinogenesis and Immune Regulation DOI Open Access

Olga Brusnic,

Danusia Onişor, Adrian Boicean

и другие.

Journal of Clinical Medicine, Год журнала: 2024, Номер 13(21), С. 6578 - 6578

Опубликована: Ноя. 1, 2024

Colorectal cancer (CRC) constitutes a significant global health challenge, with recent studies underscoring the pivotal role of gut microbiome in its pathogenesis and progression. Fecal microbiota transplantation (FMT) has emerged as compelling therapeutic approach, offering potential to modulate microbial composition optimize treatment outcomes. Research suggests that specific bacterial strains are closely linked CRC, influencing both clinical management interventions. Moreover, microbiome's impact on immunotherapy responsiveness heralds new avenues for personalized medicine. Despite promise FMT, safety concerns, particularly immunocompromised individuals, remain critical issue. Clinical outcomes vary widely, influenced by genetic predispositions methodologies employed. Additionally, rigorous donor selection screening protocols paramount minimize risks maximize efficacy. The current body literature advocates establishment standardized further trials substantiate FMT's CRC management. As our understanding deepens, FMT is poised become cornerstone treatment, imperative continued research validation.

Язык: Английский

Процитировано

26

Molecular Mechanisms of Lacticaseibacillus rhamnosus, LGG® Probiotic Function DOI Creative Commons
Thomas D. Leser, Adam Baker

Microorganisms, Год журнала: 2024, Номер 12(4), С. 794 - 794

Опубликована: Апрель 14, 2024

To advance probiotic research, a comprehensive understanding of bacterial interactions with human physiology at the molecular and cellular levels is fundamental. Lacticaseibacillus rhamnosus LGG® strain that has long been recognized for its beneficial effects on health. Probiotic effector molecules derived from LGG®, including secreted proteins, surface-anchored polysaccharides, lipoteichoic acids, which interact host physiological processes have identified. In vitro animal studies revealed specific stimulate epithelial cell survival, preserve intestinal barrier integrity, reduce oxidative stress, mitigate excessive mucosal inflammation, enhance IgA secretion, provide long-term protection through epigenetic imprinting. Pili surface promote adhesion to mucosa ensure close contact cells. Extracellular vesicles produced by recapitulate many these their cargo molecules. Collectively, exert significant influence both gut immune system, promotes homeostasis tolerance.

Язык: Английский

Процитировано

10

Unveiling intratumoral microbiota: An emerging force for colorectal cancer diagnosis and therapy DOI Creative Commons

Jinjing Zhang,

Penghui Wang, Jiafeng Wang

и другие.

Pharmacological Research, Год журнала: 2024, Номер 203, С. 107185 - 107185

Опубликована: Апрель 12, 2024

Microbes, including bacteria, viruses, fungi, and other eukaryotic organisms, are commonly present in multiple organs of the human body contribute significantly to both physiological pathological processes. Nowadays, development sequencing technology has revealed presence composition intratumoral microbiota, which includes Fusobacterium, Bifidobacteria, Bacteroides, shed light on significant involvement progression colorectal cancer (CRC). Here, we summarized current understanding microbiota CRC outline potential translational clinical applications diagnosis, prevention, treatment CRC. We focused reviewing microbial therapies targeting improve efficacy safety chemotherapy immunotherapy for identify biomarkers diagnosis prognosis Finally, emphasized obstacles solutions translating knowledge into practice.

Язык: Английский

Процитировано

8

Clostridioides difficile and Gut Microbiota: From Colonization to Infection and Treatment DOI Creative Commons
Patrizia Spigaglia

Pathogens, Год журнала: 2024, Номер 13(8), С. 646 - 646

Опубликована: Июль 31, 2024

Clostridioides difficile is the main causative agent of antibiotic-associated diarrhea (AAD) in hospitals developed world. Both infected patients and asymptomatic colonized individuals represent important transmission sources C. difficile. infection (CDI) shows a large range symptoms, from mild to severe manifestations such as pseudomembranous colitis. Epidemiological changes CDIs have been observed last two decades, with emergence highly virulent types more numerous CDI cases community. interacts gut microbiota throughout its entire life cycle, difficile’s role colonizer or invader largely depends on alterations microbiota, which itself can promote maintain. The restoration healthy state considered potentially effective for prevention treatment CDI. Besides fecal transplantation (FMT), many other approaches re-establishing intestinal eubiosis are currently under investigation. This review aims explore current data consideration recent types, an overview microbial interventions used restore human microbiota.

Язык: Английский

Процитировано

8

Protective Effects of Bifidobacterium Breve MCC1274 as a Novel Therapy for Alzheimer’s Disease DOI Open Access
Mona Abdelhamid, Scott Counts, Chunyu Zhou

и другие.

Nutrients, Год журнала: 2025, Номер 17(3), С. 558 - 558

Опубликована: Янв. 31, 2025

Alzheimer’s disease (AD) is the most common form of dementia and characterized by memory impairment that significantly interferes with daily life. Therapeutic options for AD substantively modify progression remain a critical unmet need. In this regard, gut microbiota crucial in maintaining human health regulating metabolism immune responses, increasing evidence suggests probiotics, particularly beneficial bacteria, can enhance cognitive functions. Recent studies have highlighted positive effects Bifidobacterium breve MCC1274 (B. MCC1274) on individuals mild (MCI) schizophrenia. Additionally, oral supplementation B. has been shown to effectively prevent decline AppNL–G–F mice. relation pathology, found reduce amyloid-β (Aβ) accumulation tau phosphorylation both wild-type (WT) It also decreases microglial activation increases levels synaptic proteins. review, we examine AD, exploring potential mechanisms action how probiotic strain may aid preventing or treating disease. Furthermore, discuss broader implications improving overall host provide insights into future research directions promising therapy.

Язык: Английский

Процитировано

1

Gut Microecological Prescription: A Novel Approach to Regulating Intestinal Micro-Ecological Balance DOI Creative Commons
Lingping Zhu, Xuefeng Yang

International Journal of General Medicine, Год журнала: 2025, Номер Volume 18, С. 603 - 626

Опубликована: Фев. 1, 2025

Abstract: The intestinal microecology is comprises microorganisms and other components constituting the entire ecosystem, presenting characteristics of stability dynamic balance. Current research reveals microecological imbalances are related to various diseases. However, fundamental clinical applications have not been effectively integrated. Considering importance complexity regulating balance, this study provides an overview high-risk factors affecting detection methods. Moreover, it proposes definition imbalance definition, formulation, outcomes gut prescription facilitate its application in practice, thus promoting on improving quality life population. Keywords: microecology, risk, prescription, faecal microbiota transplantation

Язык: Английский

Процитировано

1

Modulation of the Neuro–Cancer Connection by Metabolites of Gut Microbiota DOI Creative Commons
Alice Njolke Mafe, Dietrich Büsselberg

Biomolecules, Год журнала: 2025, Номер 15(2), С. 270 - 270

Опубликована: Фев. 12, 2025

The gut-brain-cancer axis represents a novel and intricate connection between the gut microbiota, neurobiology, cancer progression. Recent advances have accentuated significant role of microbiota metabolites in modulating systemic processes that influence both brain health tumorigenesis. This paper explores emerging concept metabolite-mediated modulation within connection, focusing on key such as short-chain fatty acids (SCFAs), tryptophan derivatives, secondary bile acids, lipopolysaccharides (LPS). While microbiota's impact immune regulation, neuroinflammation, tumor development is well established, gaps remain grasping how specific contribute to neuro-cancer interactions. We discuss with potential implications for neurobiology cancer, indoles polyamines, which yet be extensively studied. Furthermore, we review preclinical clinical evidence linking dysbiosis, altered metabolite profiles, tumors, showcasing limitations research gaps, particularly human longitudinal studies. Case studies investigating microbiota-based interventions, including dietary changes, fecal transplantation, probiotics, demonstrate promise but also indicate hurdles translating these findings therapies. concludes call standardized multi-omics approaches bi-directional frameworks integrating microbiome, neuroscience, oncology develop personalized therapeutic strategies patients.

Язык: Английский

Процитировано

1

Genetically Engineered Bacteria as a Promising Therapeutic Strategy Against Cancer: A Comprehensive Review DOI Open Access

Zahra Zahedifard,

Shirin Mahmoodi, Abdolmajid Ghasemian

и другие.

Biotechnology and Applied Biochemistry, Год журнала: 2025, Номер unknown

Опубликована: Фев. 21, 2025

ABSTRACT As a significant cause of global mortality, the cancer has also economic impacts. In era therapy, mitigating side effects and costs overcoming drug resistance is crucial. Microbial species can grow inside tumor microenvironment inhibit growth through direct killing cells immunoregulatory effects. Although microbiota or their products have demonstrated anticancer effects, possibility acting as pathogens exerting in certain individuals risk. Hence, several genetically modified/engineered bacteria (GEB) been developed to this aim with ability diagnosing selective targeting destruction cancers. Additionally, GEB are expected be considerably more efficient, safer, permeable, less costly, invasive theranostic approaches compared wild types. Potential strains such Escherichia coli (Nissle 1917, MG1655), Salmonella typhimurium YB1 SL7207 ( aroA gene deletion), VNP20009 (∆msbB/∆purI) ΔppGpp (P Tet P BAD ), Listeria monocytogenes Lm at ‐LLO combat cells. When used tandem conventional treatments, substantially improve efficacy therapy outcomes. addition, public acceptance, optimal timing (s), duration dose identification, interactions other host cells, efficacy, safety quality, potential risks ethical dilemmas include major challenges.

Язык: Английский

Процитировано

1

Structure properties of Canna edulis RS3 (double enzyme hydrolysis) and RS4 (OS-starch and cross-linked starch): Influence on fermentation products and human gut microbiota DOI
Nan Wang, Chi Zhang,

Houxier Li

и другие.

International Journal of Biological Macromolecules, Год журнала: 2024, Номер 265, С. 130700 - 130700

Опубликована: Март 7, 2024

Язык: Английский

Процитировано

7

Population-specific differences in the human microbiome: Factors defining the diversity DOI Creative Commons
Priyanka Govender, Meenu Ghai

Gene, Год журнала: 2024, Номер 933, С. 148923 - 148923

Опубликована: Сен. 6, 2024

Язык: Английский

Процитировано

7